Whey protein lycosome formulation improves vascular functions and plasma lipids with reduction of markers of inflammation and oxidative stress in prehypertension

The Scientific World Journal

Volumn 2012, Issue , 2012, Pages

  Petyaev, Ivan M ^a   Dovgalevsky, Pavel Y ^b   Klochkov, Victor A ^b   Chalyk, Natalya E ^b   Kyle, Nigel ^a  

^a Lycotec Ltd   (United Kingdom)

^b Institute of Cardiology   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYCOPENE; MILK PROTEIN; NITRIC OXIDE; PLACEBO; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID; WHEY PROTEIN;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; BODY EWIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG FORMULATION; FEMALE; HUMAN; INFLAMMATION; MALE; MICELLE; OXIDATIVE STRESS; PREHYPERTENSION; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TISSUE OXYGENATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; AGED; BLOOD; BLOOD PRESSURE; DRUG EFFECT; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HUMANS; INFLAMMATION; LIPIDS; MALE; MIDDLE AGED; MILK PROTEINS; OXIDATIVE STRESS; PREHYPERTENSION;

MLCS; MLOWN;

EID: 84872796067     PISSN: 1537744X     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/2012/269476     Document Type: Article

References (30)

1. El-Sayed M. M. H., Chase H. A., Trends in whey protein fractionation. Biotechnology Letters 2011 33 8 1501 1511 2-s2.0-79960167633 10.1007/s10529-011-0594-8
2. Hamad E. M., Taha S. H., Abou Dawood A. G., Sitohy M. Z., Abdel-Hamid M., Protective effect of whey proteins against nonalcoholic fatty liver in rats. Lipids in Health and Disease 2011 10 57 10.1186/1476-511X-10-57
3. Aparicio V. A., Nebot E., Porres J. M., Ortega F. B., Heredia J. M., López-Jurado M., Ramírez P. A., Effects of high-whey-protein intake and resistance training on renal, bone and metabolic parameters in rats. British Journal of Nutrition 2011 105 6 836 845 2-s2.0-79955866014 10.1017/S0007114510004393
4. Oner O. Z., Oǧünç A. V., Cingi A., Uyar S. B., Yalçin A. S., Aktan A. Ö., Whey feeding suppresses the measurement of oxidative stress in experimental burn injury. Surgery Today 2006 36 4 376 381 2-s2.0-33645285902 10.1007/s00595-005-3166-5
5. Shertzer H. G., Woods S. E., Krishan M., Genter M. B., Pearson K. J., Dietary whey protein lowers the risk for metabolic disease in mice fed a high-fat diet. Journal of Nutrition 2011 141 4 582 587 2-s2.0-79955505073 10.3945/jn.110.133736
6. Bortolotti M., Maiolo E., Corazza M., Van Dijke E., Schneiter P., Boss A., Carrel G., Giusti V., KA L., Quo Chong D. G., Buehler T., Kreis R., Boesch C., Tappy L., Effects of a whey protein supplementation on intrahepatocellular lipids in obese female patients. Clinical Nutrition 2011 30 4 494 498 10.1016/j.clnu.2011.01.006
7. Chitapanarux T., Tienboon P., Pojchamarnwiputh S., Leelarungrayub D., Open-labeled pilot study of cysteine-rich whey protein isolate supplementation for nonalcoholic steatohepatitis patients. Journal of Gastroenterology and Hepatology 2009 24 6 1045 1050 2-s2.0-66549084530 10.1111/j.1440-1746.2009. 05865.x
8. Berthold H. K., Schulte D. M., Lapointe J. F., Lemieux P., Krone W., Gouni-Berthold I., The whey fermentation product malleable protein matrix decreases triglyceride concentrations in subjects with hypercholesterolemia: a randomized placebo-controlled trial1. Journal of Dairy Science 2011 94 2 589 601 2-s2.0-78751694077 10.3168/jds.2010-3115
9. Pins J. J., Keenan J. M., Effects of whey peptides on cardiovascular disease risk factors. Journal of Clinical Hypertension 2006 8 11 775 782 10.1111/j.1524-6175.2006.05667.x
10. Graf S., Egert S., Heer M., Effects of whey protein supplements on metabolism: evidence from human intervention studies. Current Opinion in Clinical Nutrition & Metabolic Care 2011 14 6 569 580 10.1097/MCO. 0b013e32834b89da
11. Batish V. K., Chander H., Zumdegeni K. C., Antibacterial activity of lactoferrin against some common food-borne pathogenic organisms. Australian Journal of Dairy Technology 1988 5 16 18
12. Early E. M., Hardy H., Forde T., Kane M., Bactericidal effect of a whey protein concentrate with anti-Helicobacter pylori activity. Journal of Applied Microbiology 2001 90 5 741 748 2-s2.0-0035029567 10.1046/j.1365-2672.2001.01301. x (Pubitemid 32391780)
13. de Aguilar-Nascimento J. E., Prado Silveira B. R., Dock-Nascimento D. B., Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: a double-blind randomized trial. Nutrition 2011 27 4 440 444 2-s2.0-79952453473 10.1016/j.nut.2010.02.013
14. Abubakar A., Saito T., Kitazawa H., Kawai Y., Itoh T., Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. Journal of Dairy Science 1998 81 12 3131 3138 2-s2.0-0032240057 (Pubitemid 128444864)
15. FitzGerald R. J., Meisel H., Lactokinins: whey protein-derived ACE inhibitory peptides. Nahrung 1999 43 3 165 167 10.1002/(SICI)1521-3803(19990601) 43:3<165::AID-FOOD165>3.0.CO;2-2 (Pubitemid 129570443)
16. Carotenoid Particles and Uses thereof, GB Patent Application No. 1101669.8, PCT/GB2012/000075, 2012
17. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L. Jr, Jones D. W., Materson B. J., Oparil S., Wright J. T. Jr, Roccella E. J., Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003 42 6 1206 1252 2-s2.0-0347423198 10.1161/01.HYP.0000107251.49515.c2 (Pubitemid 37553153)
18. Corretti M. C., Anderson T. J., Benjamin E. J., Celermajer D., Charbonneau F., Creager M. A., Deanfield J., Drexler H., Gerhard-Herman M., Herrington D., Vallance P., Vita J., Vogel R., Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. Journal of the American College of Cardiology 2002 39 2 257 265 2-s2.0-0037116573 10.1016/S0735-1097(01)01746-6 (Pubitemid 34084631)
19. Bianchini E., Faita F., Gemignani V., Giannoni M., Demi M., The assessment of flow-mediated dilation (FMD) of the brachial artery. Computers in Cardiology 2006 33 509 512
20. Celermajer D. S., Sorensen K. E., Gooch V. M., Spiegelhalter D. J., Miller O. I., Sullivan I. D., Lloyd J. K., Deanfield J. E., Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet 1992 340 8828 1111 1115 2-s2.0-0026478022 10.1016/0140-6736(92)93147-F
21. Anderson T. J., Arterial stiffness or endothelial dysfunction as a surrogate marker of vascular risk. Canadian Journal of Cardiology 2006 21 72B 80B (Pubitemid 44963575)
22. Lind L., Arterial stiffness, but not endothelium-dependent vasodilation, is related to a low ankle-brachial index in the elderly-the prospective investigation of the vasculature in uppsala seniors (PIVUS) study. The Open Atherosclerosis & Thrombosis Journal 2008 1 1 5
23. Siafaka A., Angelopoulos E., Kritikos K., Poriazi M., Basios N., Gerovasili V., Andreou A., Roussos C., Nanas S., Acute effects of smoking on skeletal muscle microcirculation monitored by near-infrared spectroscopy. Chest 2007 131 5 1479 1485 2-s2.0-34248548639 10.1378/chest.06-2017 (Pubitemid 46762356)
24. Madsen P. L., Secher N. H., Near-infrared oximetry of the brain. Progress in Neurobiology 1999 58 6 541 560 10.1016/S0301-0082(98)00093-8 (Pubitemid 29268400)
25. Bezemer R., Lima A., Myers D., Klijn E., Heger M., Goedhart P. T., Bakker J., Ince C., Assessment of tissue oxygen saturation during a vascular occlusion test using near-infrared spectroscopy: the role of probe spacing and measurement site studied in healthy volunteers. Critical Care 2009 13 supplement 5 1 7
26. Gómez H., Mesquida J., Simon P., Kim H. K., Puyana J. C., Ince C., Pinsky M. R., Characterization of tissue oxygen saturation and the vascular occlusion test: influence of measurement sites, probe sizes and deflation thresholds. Critical Care 2009 13 supplement 3 1 7 2-s2.0-77955908550
27. Yagi K., Lipid peroxides and human diseases. Chemistry and Physics of Lipids 1987 45 2-4 337 351 2-s2.0-0023239754 (Pubitemid 17152340)
28. Petyaev I., Mitchinson M. M. J., Hunt J. V., Coussons P. J., Superoxide dismutase activity of antibodies purified from the human arteries andatherosclerotic lesions. Biochemical Society Transactions 1998 26 1 S43 2-s2.0-0031906969
29. Petyaev I. M., Coussons P. J., Superoxide dismutase activity of antibodies purified from human atherosclerotic lesions. Superoxide Dismutase: Recent Advances and Clinical Applications 1999 Paris, France Editions Mel 51 54
30. De Boer M. P., Meijer R. I., Wijnstok N. J., Jonk A. M., Houben A. J., Stehouwer C. D., Smulders Y. M., Eringa E. C., Serné E. H., Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation 2012 19 1 5 18 10.1111/j.1549-8719.2011.00130.x